The Neuroendocrine Circuitry Controlled by POMC, MSH, and AGRP
The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Abstract
Obesity is one of the most challenging health problems worldwide. Over the past few decades, our knowledge concerning mechanisms of weight regulation has increased tremendously leading to the identification of the leptin-melanocortin pathway. The filling level of energy stores is signaled to the brain, and the information is integrated by hypothalamic nuclei, resulting in a well-orchestrated response to food intake and energy expenditure to ensure constant body weight. One of the key players in this system is proopiomelanocortin (POMC), a precursor of a variety of neuropeptides. POMC-derived alpha- and beta-MSH play an important role in energy homeostasis by activating melanocortin receptors expressed in the arcuate nucleus (MC3R) and in the nucleus paraventricularis (MC4R). Activation of these two G protein-coupled receptors is antagonized by agouti-related peptide (AgRP). Naturally occurring mutations in this system were identified in patients suffering from common obesity as well as in patients demonstrating a phenotype of severe early-onset obesity, adrenal insufficiency, red hair, and pale skin. Detailed understanding of the complex system of POMC-AgRP-MC3R-MC4R and their interaction with other hypothalamic as well as peripheral signals is a prerequisite to combat the obesity epidemic.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Melanin-concentrating hormone (MCH) promotes food consumption by acting directly on the lateral nucleus of the hypothalamus.”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [101]
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419 · cited 2×
“Within the arcuate nucleus of the hypothalamus (ARC), binding of leptin ((Zhang et al. 1994), see chapter by JulianMercer/Elizabeth Cottrell) to the leptin receptor on one set of neurons activates the formation of anorexigenic acting neurotransmitters generated from the precursor protein proopiomelanocortin (POMC).”
BackgroundSerum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030 · cited 1×
“Target disruption of the MC4R in mice results in maturity onset of severe obesity, hyperphagia, hyperinsulinemia, and hyperglycemia (Huszar et al. 1997).”
BackgroundAntagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
Ollmann, M. M., Wilson, B. D., Yang, Y.-K., Kerns, J. A., Chen, Y., Gantz, I., & Barsh, G. S. (1997) · Science · doi:10.1126/science.278.5335.135 · Cited by 1,881 · cited 1×
“Comparison of expressed sequence tag database with agouti led to the identification of AgRP (Graham et al. 1997; Ollmann et al. 1997).”
BackgroundKrude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G., & Grüters, A. (1998) · Nature Genetics · doi:10.1038/509 · Cited by 1,733
Self-citationGenetic and Environmental Factors in Relative Body Weight and Human Adiposity
Maes, H. H. M., Neale, M. C., & Eaves, L. J. (1997) · Behavior Genetics · doi:10.1023/a:1025635913927 · Cited by 1,515 · cited 1×
“Results of several twin studies have underlined the role of genetic factors in body-weight regulation (Maes et al. 1997).”
BackgroundCommon variants near MC4R are associated with fat mass, weight and risk of obesity
The Prostate, L., Loos, R. J. F., KORA, Study, N. H., Initiative, D. G., Study, T. S., The Wellcome Trust Case Control Consortium, FUSION, Lindgren, C. M., Li, S., et al. (2008) · Nature Genetics · doi:10.1038/ng.140 · Cited by 1,325
A frameshift mutation in MC4R associated with dominantly inherited human obesity
Yeo, G. S. H., Farooqi, I. S., Aminian, S., Halsall, D. J., Stanhope, R. G., & O'Rahilly, S. (1998) · Nature Genetics · doi:10.1038/2404 · Cited by 1,159 · cited 2×
“The first inactivating mutations in theMC4R gene were described in 1998 by two independent groups (Vaisse et al. 1998; Yeo et al. 1998).”
BackgroundNPY/AgRP Neurons Are Essential for Feeding in Adult Mice but Can Be Ablated in Neonates
Luquet, S., Perez, F. A., Hnasko, T. S., & Palmiter, R. D. (2005) · Science · doi:10.1126/science.1115524 · Cited by 1,125 · cited 1×
“Thereby, ablation of AgRP neurons could be generated by administration of diphtheria toxin (Gropp et al. 2005; Luquet et al. 2005).”
BackgroundDivergence of Melanocortin Pathways in the Control of Food Intake and Energy Expenditure
Balthasar, N., Dalgaard, L. T., Lee, C. E., Yu, J., Funahashi, H., Williams, T., Ferreira, M., Tang, V., McGovern, R. A., Kenny, C. D., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.035 · Cited by 1,120 · cited 1×
“By rescue of MC4R expression in the nucleus paraventricularis (PVN) of MC4R knockout mice, it was demonstrated that MC4R function in the PVN is responsible for food intake, whereas MC4R expression in other brain areas are involved in energy expenditure (Balthasar et al. 2005).”
BackgroundA frameshift mutation in human MC4R is associated with a dominant form of obesity
Vaisse, C., Clement, K., Guy-Grand, B., & Froguel, P. (1998) · Nature Genetics · doi:10.1038/2407 · Cited by 1,100 · cited 2×
“The first patients with a mutation in the MC4R were discovered in 1998 (Vaisse et al. 1998; Yeo et al. 1998).”
BackgroundObesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin
Yaswen, L., Diehl, N., Brennan, M. B., & Hochgeschwender, U. (1999) · Nature Medicine · doi:10.1038/12506 · Cited by 1,012
Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor
Xu, B., Goulding, E. H., Zang, K., Cepoi, D., Cone, R. D., Jones, K. R., Tecott, L. H., & Reichardt, L. F. (2003) · Nature Neuroscience · doi:10.1038/nn1073 · Cited by 896 · cited 1×
“BDNF expression is mediated by nutritional state and by MC4R signaling (Xu et al. 2003).”
BackgroundChen, A. S., Marsh, D. J., Trumbauer, M. E., Frazier, E. G., Guan, X.-M., Yu, H., Rosenblum, C. I., Vongs, A., Feng, Y., Cao, L., et al. (2000) · Nature Genetics · doi:10.1038/79254 · Cited by 894
Molecular cloning, expression, and gene localization of a fourth melanocortin receptor
Gantz, I., Miwa, H., Konda, Y., Shimoto, Y., Tashiro, T., Watson, S. J., DelValle, J., & Yamada, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82452-8 · Cited by 845
Farooqi, I. S., Yeo, G. S. H., Keogh, J. M., Aminian, S., Jebb, S. A., Butler, G., Cheetham, T., & O’Rahilly, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9397 · Cited by 815
Agouti-related peptide–expressing neurons are mandatory for feeding
Gropp, E., Shanabrough, M., Borok, E., Xu, A. W., Janoschek, R., Buch, T., Plum, L., Balthasar, N., Hampel, B., Waisman, A., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1548 · Cited by 798 · cited 2×
“Thereby, ablation of AgRP neurons could be generated by administration of diphtheria toxin (Gropp et al. 2005; Luquet et al. 2005).”
BackgroundIncidence and precursors of hypertension in young adults: The Framingham offspring study
Garrison, R. J., Kannel, W. B., Stokes, J., & Castelli, W. P. (1987) · Preventive Medicine · doi:10.1016/0091-7435(87)90087-9 · Cited by 789 · cited 1×
“Moreover, although obesity is one of the major causes of hypertension (Garrison et al. 1987), studies reveal a decreased prevalence of hypertension in MC4R patients.”
BackgroundGenetics of body-weight regulation
Barsh, G. S., Farooqi, I. S., & O'Rahilly, S. (2000) · Nature · doi:10.1038/35007519 · Cited by 778 · cited 1×
“Recently, mutations in the human homologues of these keyregulator genes of bodyweightmaintenancewere found in cases of extreme and earlyonset obesity, suggesting a high level of functional conservation of the set-point genes during evolution (Barsh et al. 2000).”
BackgroundA Unique Metalolic Sysdrone Causes Obesity in the Melanocortin-3 Receptor-Deficient Mouse
Butler, A. A., Kesteson, R. A., Khong, K., Cullen, M. J., Pelleymounter, M. A., DeKoning, J., Baetscher, M., & Cone, R. D. (2000) · Endocrinology · doi:10.1210/en.141.9.3518 · Cited by 701
Response of melanocortin–4 receptor–deficient mice to anorectic and orexigenic peptides
Marsh, D. J., Hollopeter, G., Huszar, D., Laufer, R., Yagaloff, K. A., Fisher, S. L., Burn, P., & Palmiter, R. D. (1999) · Nature Genetics · doi:10.1038/5070 · Cited by 542 · cited 1×
“So far, it was recognized that injection of corticotropin-releasing hormone reduces food intake, and this is also true for MC4R knockout mice (Lu et al. 2003; Marsh et al. 1999).”
BackgroundThe Melanocortin-4 Receptor: Physiology, Pharmacology, and Pathophysiology
Tao, Y.-X. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0037 · Cited by 531
Common genetic variation near MC4R is associated with waist circumference and insulin resistance
Chambers, J. C., Elliott, P., Zabaneh, D., Zhang, W., Li, Y., Froguel, P., Balding, D., Scott, J., & Kooner, J. S. (2008) · Nature Genetics · doi:10.1038/ng.156 · Cited by 497
Modulation of Blood Pressure by Central Melanocortinergic Pathways
Greenfield, J. R., Miller, J. W., Keogh, J. M., Henning, E., Satterwhite, J. H., Cameron, G. S., Astruc, B., Mayer, J. P., Brage, S., See, T. C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803085 · Cited by 477
Hinney, A. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.4.1483 · Cited by 462 · cited 1×
“Besides frequent variants that predispose to obesity, two variants were indentified that protect against obesity, Val103Ile (rs2229616) and Ile251Leu (rs52820871) (Gotoda et al. 1997; Hinney et al. 1999).”
BackgroundNeomorphic agouti mutations in obese yellow mice
Duhl, D. M. J., Vrieling, H., Miller, K. A., Wolff, G. L., & Barsh, G. S. (1994) · Nature Genetics · doi:10.1038/ng0994-59 · Cited by 448
Metherell, L. A., Chapple, J. P., Cooray, S., David, A., Becker, C., Rüschendorf, F., Naville, D., Begeot, M., Khoo, B., Nürnberg, P., et al. (2005) · Nature Genetics · doi:10.1038/ng1501 · Cited by 437 · cited 1×
“This is also true for the MC2R which depends on the interaction with melanocortin receptor 2 accessory protein (MRAP) for proper cell surface expression (Metherell et al. 2005).”
BackgroundQian, S., Chen, H., Weingarth, D., Trumbauer, M. E., Novi, D. E., Guan, X., Yu, H., Shen, Z., Feng, Y., Frazier, E., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5027-5035.2002 · Cited by 430 · cited 1×
“The AgRP knockout mouse shows a remarkably normal phenotype (Qian et al. 2002).”
BackgroundAgRP(83-132) Acts as an Inverse Agonist on the Human-Melanocortin-4 Receptor
Nijenhuis, W. A. J. (2001) · Molecular Endocrinology · doi:10.1210/me.15.1.164 · Cited by 406 · cited 1×
“Similar to agouti, AgRP (both containing an Arg-Phe-Phe motif) is able to antagonize MSH stimulation of MC3R and MC4R as an antagonist and inverse agonist (Fu and van den Pol 2008; Haskell-Luevano and Monck 2001; Nijenhuis et al. 2001; Oosterom et al. 2001).”
BackgroundOverexpression of Agrt leads to obesity in transgenic mice
Graham, M., Shutter, J. R., Sarmiento, U., Sarosi, L., & Stark, K. L. (1997) · Nature Genetics · doi:10.1038/ng1197-273 · Cited by 387 · cited 1×
“Comparison of expressed sequence tag database with agouti led to the identification of AgRP (Graham et al. 1997; Ollmann et al. 1997).”
BackgroundA genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10
Hager, J., Dina, C., Francke, S., Dubois, S., Houari, M., Vatin, V., Vaillant, E., Lorentz, N., Basdevant, A., Clement, K., et al. (1998) · Nature Genetics · doi:10.1038/3123 · Cited by 369
A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors
Ste. Marie, L., Miura, G. I., Marsh, D. J., Yagaloff, K., & Palmiter, R. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220409497 · Cited by 366
Hrubu, V. J., Lu, D., Sharma, S. D., de L. Castrucci, A., Kesterson, R. A., Al-Obeidi, F. A., Hadley, M. E., & Cone, R. D. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00018a005 · Cited by 348 · cited 1×
“In contrast, cyclic lactam analogs with a bulkier amino acid as phenylalanine at position 7, D-p-iodophenylalanine 7, exert antagonistic activity at the MC4R (Hruby et al. 1995).”
BackgroundMünzberg, H., Huo, L., Nillni, E. A., Hollenberg, A. N., & Bjørbæk, C. (2003) · Endocrinology · doi:10.1210/en.2002-221037 · Cited by 328 · cited 1×
“Leptin-induced STAT3 expression was shown to modulate expression of POMC (Munzberg et al. 2003).”
BackgroundObesity, diabetes, and neoplasia in yellow A vy /‐ mice: ectopic expression of the agouti gene
Yen, T. T., Gill, A. M., Frigeri, L. G., Barsh, G. S., & Wolff, G. L. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.8.8181666 · Cited by 308 · cited 1×
“Heterozygous A animals are viable, but in the mutated allele, the Raly promoter drives ubiquitous expression of agouti resulting in the described phenotype (Miltenberger et al. 1999; Yen et al. 1994).”
BackgroundKrude, H., Biebermann, H., Schnabel, D., Tansek, M. Z., Theunissen, P., Mullis, P. E., & Grüters, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030502 · Cited by 307
Self-citationA role for the melanocortin 4 receptor in sexual function
Van der Ploeg, L. H. T., Martin, W. J., Howard, A. D., Nargund, R. P., Austin, C. P., Guan, X., Drisko, J., Cashen, D., Sebhat, I., Patchett, A. A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172378699 · Cited by 303
Challis, B. G. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.17.1997 · Cited by 288
Stutzmann, F., Tan, K., Vatin, V., Dina, C., Jouret, B., Tichet, J., Balkau, B., Potoczna, N., Horber, F., O'Rahilly, S., et al. (2008) · Diabetes · doi:10.2337/db08-0153 · Cited by 279
.alpha.-Melanotropin: the minimal active sequence in the frog skin bioassay
Hruby, V. J., Wilkes, B. C., Hadley, M. E., Al-Obeidi, F., Sawyer, T. K., Staples, D. J., DeVaux, A. E., Dym, O., & Castrucci, A. M. D. L. (1987) · Journal of Medicinal Chemistry · doi:10.1021/jm00394a033 · Cited by 271 · cited 1×
“The core sequence of alpha-, beta-, and gamma-MSH as well as ACTH that is needed for activation of melanocortin receptors consists of a specific motif of four amino acids: histidine, phenylalanine, arginine, and tryptophan (His-Phe-Arg-Trp motif) (Table 1) (Hruby et al. 1987).”
BackgroundHaskell-Luevano, C., & Monck, E. K. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(01)00234-8 · Cited by 252 · cited 1×
“Similar to agouti, AgRP (both containing an Arg-Phe-Phe motif) is able to antagonize MSH stimulation of MC3R and MC4R as an antagonist and inverse agonist (Fu and van den Pol 2008; Haskell-Luevano and Monck 2001; Nijenhuis et al. 2001; Oosterom et al. 2001).”
BackgroundHormone and glucose signalling in POMC and AgRP neurons
Belgardt, B. F., Okamura, T., & Brüning, J. C. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.179192 · Cited by 244 · cited 1×
“release has been shown to inhibit POMC positive neurons in the hypothalamus (Belgardt et al. 2009).”
BackgroundLu, X.-Y., Barsh, G. S., Akil, H., & Watson, S. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07863.2003 · Cited by 241
ACTH-(1–24) and α-MSH antagonize feeding behavior stimulated by kappa opiate agonists
Poggioli, R., Vergoni, A. V., & Bertolini, A. (1986) · Peptides · doi:10.1016/0196-9781(86)90104-x · Cited by 237 · cited 1×
“As early as in the 1980s, it was shown in rats that intracerebroventricular injection of alpha-MSH or of ACTH decreases food intake (Poggioli et al. 1986; Vergoni et al. 1986).”
BackgroundMRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family
Chan, L. F., Webb, T. R., Chung, T.-T., Meimaridou, E., Cooray, S. N., Guasti, L., Chapple, J. P., Egertová, M., Elphick, M. R., Cheetham, M. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809918106 · Cited by 237
Postembryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype
Bewick, G. A., Gardiner, J. V., Dhillo, W. S., Kent, A. S., White, N. E., Webster, Z., Ghatei, M. A., & Bloom, S. R. (2005) · The FASEB Journal · doi:10.1096/fj.04-3434fje · Cited by 235 · cited 1×
“In one study, transgenic expression of the CAG expanded repeat form of ataxin-3 in AgRP, which induces cell death, was generated (Bewick et al. 2005).”
BackgroundA POMC variant implicates β-melanocyte-stimulating hormone in the control of human energy balance
Lee, Y. S., Challis, B. G., Thompson, D. A., Yeo, G. S. H., Keogh, J. M., Madonna, M. E., Wraight, V., Sims, M., Vatin, V., Meyre, D., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.006 · Cited by 234
Heterozygosity for a POMC-Null Mutation and Increased Obesity Risk in Humans
Farooqi, I. S., Drop, S., Clements, A., Keogh, J. M., Biernacka, J., Lowenbein, S., Challis, B. G., & O’Rahilly, S. (2006) · Diabetes · doi:10.2337/db06-0214 · Cited by 233 · cited 3×
“So far, only a few patients were reported (Table 2; (Clement et al. 2008; Farooqi et al. 2006; Krude et al. 1998, 2003)) as suffering from adrenal insufficiency and early-onset obesity.”
BackgroundInfluentialMelanocortin-4 Receptor Gene Variant I103 Is Negatively Associated with Obesity
Geller, F., Reichwald, K., Dempfle, A., Illig, T., Vollmert, C., Herpertz, S., Siffert, W., Platzer, M., Hess, C., Gudermann, T., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/382490 · Cited by 217
Self-citationHinney, A., Bettecken, T., Tarnow, P., Brumm, H., Reichwald, K., Lichtner, P., Scherag, A., Nguyen, T. T., Schlumberger, P., Rief, W., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2056 · Cited by 209 · cited 1×
“15% have a mutation of functional relevance (Hinney et al. 2006).”
BackgroundSelf-citationHinney, A., Hohmann, S., Geller, F., Vogel, C., Hess, C., Wermter, A.-K., Brokamp, B., Goldschmidt, H., Siegfried, W., Remschmidt, H., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030233 · Cited by 207 · cited 1×
“Taking these findings together, it is suggested that inactivating mutations in the MC4R do not comprise a form of monogenic but of oligogenic obesity (Dempfle et al. 2004; Hinney et al. 2003), indicating that inactivating MC4R mutations can but do not always predispose for obesity.”
BackgroundMolecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity
Tao, Y.-X. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.04.012 · Cited by 196 · cited 1×
“Due to their functional consequences, the mutations were grouped into five classes (Tao 2005): Class I: null mutations.”
BackgroundSebhat, I. K., Martin, W. J., Ye, Z., Barakat, K., Mosley, R. T., Johnston, D. B. R., Bakshi, R., Palucki, B., Weinberg, D. H., MacNeil, T., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025539h · Cited by 193
Stutzmann, F., Vatin, V., Cauchi, S., Morandi, A., Jouret, B., Landt, O., Tounian, P., Levy-Marchal, C., Buzzetti, R., Pinelli, L., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm132 · Cited by 188
A role for β-melanocyte-stimulating hormone in human body-weight regulation
Biebermann, H., Castañeda, T. R., van Landeghem, F., von Deimling, A., Escher, F., Brabant, G., Hebebrand, J., Hinney, A., Tschöp, M. H., Grüters, A., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.007 · Cited by 185 · cited 4×
“beta-MSH or alpha-MSH was not sufficient to inhibit food intake (Biebermann et al. 2006).”
BackgroundSelf-citationMolecular Determinants of Ligand Binding to the Human Melanocortin-4 Receptor
Yang, Y.-K., Fong, T. M., Dickinson, C. J., Mao, C., Li, J.-Y., Tota, M. R., Mosley, R., Van der Ploeg, L. H. T., & Gantz, I. (2000) · Biochemistry · doi:10.1021/bi001684q · Cited by 170 · cited 2×
“2003) are of less importance for ligand binding (Schioth et al. 1997; Yang et al. 2000).”
BackgroundBiebermann, H., Krude, H., Elsner, A., Chubanov, V., Gudermann, T., & Grüters, A. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2984 · Cited by 166
Self-citation(2000) · Humana Press eBooks · doi:10.1007/978-1-59259-031-5 · Cited by 163
Implications of Proopiomelanocortin (POMC) Mutations in Humans: The POMC Deficiency Syndrome
Krude, H., & Grüters, A. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(99)00213-1 · Cited by 162
Self-citationA Novel Melanocortin 3 Receptor Gene (MC3R) Mutation Associated with Severe Obesity
Lee, Y.-S. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.3.1423 · Cited by 154 · cited 2×
“The first identified mutation of the MC3R Ile183Asn is located in transmembrane helix 3 and was detected in an obese child and father (Lee et al. 2002).”
BackgroundMartinelli, C. E., Keogh, J. M., Greenfield, J. R., Henning, E., van der Klaauw, A. A., Blackwood, A., O'Rahilly, S., Roelfsema, F., Camacho-Hübner, C., Pijl, H., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1369 · Cited by 153
Hypothalamic and vagal neuropeptide circuitries regulating food intake
Broberger, C., & Hökfelt, T. G. M. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(01)00611-4 · Cited by 152 · cited 1×
“Central AgRP administration or AgRP overexpression leads to hyperphagia and obesity (Barsh et al. 1999; Broberger and Hokfelt 2001).”
BackgroundXiang, Z., Litherland, S. A., Sorensen, N. B., Proneth, B., Wood, M. S., Shaw, A. M., Millard, W. J., & Haskell-Luevano, C. (2006) · Biochemistry · doi:10.1021/bi0600300 · Cited by 145
Investigation of the melanocyte stimulating hormones on food intake
Abbott, C. R., Rossi, M., Kim, M.-S., AlAhmed, S. H., Taylor, G. M., Ghatei, M. A., Smith, D. M., & Bloom, S. R. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02386-6 · Cited by 144
Sutton, G. M., Duos, B., Patterson, L. M., & Berthoud, H.-R. (2005) · Endocrinology · doi:10.1210/en.2005-0562 · Cited by 140 · cited 2×
“In addition to activation of the Gs-signaling pathway, it was shown in vivo that the suppression of food intake requires the induction of extracellular signal-regulated kinase (ERK) 1/2 (Sutton et al. 2005).”
BackgroundSutton, G. M., Trevaskis, J. L., Hulver, M. W., McMillan, R. P., Markward, N. J., Babin, M. J., Meyer, E. A., & Butler, A. A. (2006) · Endocrinology · doi:10.1210/en.2005-1209 · Cited by 139
Structure, function and regulation of the melanocortin receptors
Yang, Y. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.12.020 · Cited by 139 · cited 1×
“Within the TMHs, ionic and aromatic residues are mainly responsible for high affinity ligand binding (reviewed in (Tao 2010a; Yang 2011)).”
BackgroundAgouti: from Mouse to Man, from Skin to Fat
Voisey, J., & Van Daal, A. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.00039.x · Cited by 134
Large quantitative effect of melanocortin-4 receptor gene mutations on body mass index
Dempfle, A., Hinney, A., Heinzel-Gutenbrunner, M., Raab, M., Geller, F., Gudermann, T., Schäfer, H., & Hebebrand, J. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.018614 · Cited by 132
Agouti-related protein-deficient mice display an age-related lean phenotype
Wortley, K. E., Anderson, K. D., Yasenchak, J., Murphy, A., Valenzuela, D., Diano, S., Yancopoulos, G. D., Wiegand, S. J., & Sleeman, M. W. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.11.004 · Cited by 128 · cited 1×
“Subsequent studies identified a modest lean phenotype with reduced body weight after 6 months, with increased metabolic rate, locomotor activity, and thyroid hormone levels (Wortley et al. 2005).”
BackgroundCalton, M. A., Ersoy, B. A., Zhang, S., Kane, J. P., Malloy, M. J., Pullinger, C. R., Bromberg, Y., Pennacchio, L. A., Dent, R., McPherson, R., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn431 · Cited by 128
Physiological consequences of ectopic agouti gene expression: the yellow obese mouse syndrome
WOLFF, G. L., ROBERTS, D. W., & MOUNTJOY, K. G. (1999) · Physiological Genomics · doi:10.1152/physiolgenomics.1999.1.3.151 · Cited by 125 · cited 1×
“A mice result from an insertion of an intracisternal A particle (IAP) into the noncoding exon 1A (Duhl et al. 1994; Wolff et al. 1999).”
BackgroundFunctional Characterization of Mutations in Melanocortin-4 Receptor Associated with Human Obesity
Ho, G., & MacKenzie, R. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35816 · Cited by 121 · cited 1×
“For the first two identified frameshift mutations, a dominant-negative effect was not found (Ho and MacKenzie 1999).”
BackgroundKublaoui, B. M., Holder, J. L., Gemelli, T., & Zinn, A. R. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0483 · Cited by 121
Slominski, A., Plonka, P. M., Pisarchik, A., Smart, J. L., Tolle, V., Wortsman, J., & Low, M. J. (2005) · Endocrinology · doi:10.1210/en.2004-0733 · Cited by 117 · cited 1×
“that the genetic background has a strong influence on coat color (Slominski et al. 2005).”
BackgroundHeid, I. M., Vollmert, C., Hinney, A., Döring, A., Geller, F., Löwel, H., Wichmann, H.-E., Illig, T., Hebebrand, J., & Kronenberg, F. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.027011 · Cited by 114 · cited 1×
“2004); therefore, large sample sizes are needed to obtain sufficient power for the identification of small effects (Heid et al. 2005).”
BackgroundFeng, N., Young, S. F., Aguilera, G., Puricelli, E., Adler-Wailes, D. C., Sebring, N. G., & Yanovski, J. A. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2663 · Cited by 114 · cited 3×
“With the exception of obese children which are homozygous for both polymorphisms (Feng et al. 2005), no association with obesity could be found in these studies.”
BackgroundThe Melanocortin Melanocyte-Stimulating Hormone/Adrenocorticotropin4–10Decreases Body Fat in Humans1
Fehm, H. L., Smolnik, R., Kern, W., McGregor, G. P., Bickel, U., & Born, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7298 · Cited by 113 · cited 1×
“The first study to reduce bodyweight in humans usesACTH4-10whichwas found to be effective in healthy adults (Fehm et al. 2001).”
BackgroundBüch, T. R. H., Heling, D., Damm, E., Gudermann, T., & Breit, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.039339 · Cited by 106 · cited 2×
“Additionally, pertussis toxin-sensitive MC4R signaling in hypothalamic mouse GT1-7 implicates activation of Gi/o-mediated signaling (Buch et al. 2009).”
BackgroundMelanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells
MOUNTJOY, K. G., KONG, P. L., TAYLOR, J. A., WILLARD, D. H., & WILKISON, W. O. (2001) · Physiological Genomics · doi:10.1152/physiolgenomics.2001.5.1.11 · Cited by 104
Kobayashi, H., Ogawa, Y., Shintani, M., Ebihara, K., Shimodahira, M., Iwakura, T., Hino, M., Ishihara, T., Ikekubo, K., Kurahachi, H., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.1.243 · Cited by 103 · cited 1×
“Since these first descriptions, so far over 150 different mutations in theMC4R gene have been identified (summarized in (Tao 2010a)) with only rare cases in which homozygous or compound heterozygous mutations were identified (Farooqi et al. 2000, 2003; Kobayashi et al. 2002; LubranoBerthelier et al. 2004; Ma et al. 20…”
BackgroundHinney, A. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.10.3737 · Cited by 102 · cited 4×
“These mutations were located in the prohormone convertase recognition site between beta-MSH and beta-endorphin (Challis et al. 2002; Hinney et al. 1998) and result in a beta-MSH/ beta-endorphin fusion protein lowering the amount of functional beta-MSH.”
BackgroundInfluentialClément, K., Dubern, B., Mencarelli, M., Czernichow, P., Ito, S., Wakamatsu, K., Barsh, G. S., Vaisse, C., & Leger, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1164 · Cited by 96
The Role of Melanocortin 3 Receptor Gene in Childhood Obesity
Seng Lee, Y., Kok Seng Poh, L., Lay Kee Kek, B., & Yin Loke, K. (2007) · Diabetes · doi:10.2337/db07-0225 · Cited by 95 · cited 1×
“These mutations display either wild-type-like receptor signaling functions (Ala293Thr, Val177Ile, X361Ser, Ala70Thr, Met134Ile) (Lee et al. 2007; Mencarelli et al. 2008; Rached et al. 2004) or reduced signaling properties (Ser17Thr, Thr280Ser, and Ile335Ser, c.”
BackgroundA Homozygous Null Mutation Delineates the Role of the Melanocortin-4 Receptor in Humans
Lubrano-Berthelier, C., Le Stunff, C., Bougnères, P., & Vaisse, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031993 · Cited by 93
Binge Eating as a Phenotype of Melanocortin 4 Receptor Gene Mutations
Herpertz, S., Siffert, W., & Hebebrand, J. (2003) · New England Journal of Medicine · doi:10.1056/nejm200308073490615 · Cited by 90
Gotoda, T., Scott, J., & Aitman, T. J. (1997) · Diabetologia · doi:10.1007/s001250050777 · Cited by 88 · cited 1×
“Besides frequent variants that predispose to obesity, two variants were indentified that protect against obesity, Val103Ile (rs2229616) and Ile251Leu (rs52820871) (Gotoda et al. 1997; Hinney et al. 1999).”
BackgroundKrishna, R., Gumbiner, B., Stevens, C., Musser, B., Mallick, M., Suryawanshi, S., Maganti, L., Zhu, H., Han, T. H., Scherer, L., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.167 · Cited by 87 · cited 1×
“Unfortunately in humans, MK-0493 was not effective to reduce energy intake and to induce weight loss (Krishna et al. 2009).”
BackgroundBreit, A., Büch, T., Boekhoff, I., Solinski, H. J., Damm, E., & Gudermann, T. W. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.07.007 · Cited by 85 · cited 1×
“Interestingly, AgRP is able to activate Gi simultaneously to antagonism of the Gssignaling pathway, which was referred to as a biased agonist of MC4R signaling (Breit et al. 2011; Buch et al. 2009).”
BackgroundMelanocortin receptors form constitutive homo- and heterodimers
Mandrika, I., Petrovska, R., & Wikberg, J. E. S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.036 · Cited by 85 · cited 1×
“For melanocortin receptors, it was shown that MC3R and MC4R are able to form homodimers (Biebermann et al. 2003; Elsner et al. 2006; Mandrika et al. 2005; Nickolls and Maki 2006).”
BackgroundFu, L.-Y., & van den Pol, A. N. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0749-08.2008 · Cited by 85
Tao, Y.-X., & Segaloff, D. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0367 · Cited by 85 · cited 1×
“In vitro investigation of signal transduction capabilities suggested that these single mutations do not have an impact on receptor function (Tao and Segaloff 2004).”
BackgroundTrkB Agonists Ameliorate Obesity and Associated Metabolic Conditions in Mice
Tsao, D., Thomsen, H. K., Chou, J., Stratton, J., Hagen, M., Loo, C., Garcia, C., Sloane, D. L., Rosenthal, A., & Lin, J. C. (2008) · Endocrinology · doi:10.1210/en.2007-1166 · Cited by 83 · cited 1×
“Furthermore, peripheral injection of neutrophin-4, a ligand for the BDNF receptor, TrkB (tropomyosin receptor kinase B), suppresses appetite and weight gain in a dose-dependent manner (Tsao et al. 2008).”
BackgroundCorticotropin inhibits food intake in rats
Vergoni, A. V., Poggioli, R., & Bertolini, A. (1986) · Neuropeptides · doi:10.1016/0143-4179(86)90091-0 · Cited by 79 · cited 1×
“As early as in the 1980s, it was shown in rats that intracerebroventricular injection of alpha-MSH or of ACTH decreases food intake (Poggioli et al. 1986; Vergoni et al. 1986).”
BackgroundLubrano-Berthelier, C., Cavazos, M., Le Stunff, C., Haas, K., Shapiro, A., Zhang, S., Bougneres, P., & Vaisse, C. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2996 · Cited by 77 · cited 1×
“So far, only one variation in the 50 untranslated region of MC4R was reported (Lubrano-Berthelier et al. 2003; Valli-Jaakola et al. 2006).”
BackgroundNewman, E. A., Chai, B., Zhang, W., Li, J.-Y., Ammori, J. B., & Mulholland, M. W. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2006.02.003 · Cited by 76 · cited 1×
“Activation of the Gq/11mediated pathway is controversially discussed, but so far, no physiological relevance of this pathway is known (Mountjoy et al. 2001; Newman et al. 2006).”
BackgroundDubern, B., Lubrano-Berthelier, C., Mencarelli, M., Ersoy, B. A., Frelut, M., Bouglé, D. L., Costes, B., Simon, C., Tounian, P., Vaisse, C., et al. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e31815ed62b · Cited by 74
Melanocortin 3 receptor (MC3R) gene variants in extremely obese women
Li, W., Joo, E.-J., Furlong, E., Galvin, M., Abel, K.-B., Bell, C., & Price, R. A. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801114 · Cited by 73 · cited 1×
“In the past decade, numerous studies investigated association of two frequent MC3R variants with obesity or diabetes in various collectives (Feng et al. 2005; Hani et al. 2001; Li et al. 2000; Schalin-Jantti et al. 2003; Wong et al. 2002).”
BackgroundCreemers, J. W. M., Lee, Y. S., Oliver, R. L., Bahçeci, M., Tuzcu, A., Gökalp, D., Keogh, J. M., Herber, S. M., White, A. E., O’Rahilly, S., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0954 · Cited by 72
Kask, A., Rägo, L., Wikberg, J. E. S., & Schiöth, H. B. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00837-5 · Cited by 71 · cited 1×
“The in vivo difference of the two forms may be related to the higher stability of acetylated alpha-MSH (Abbott et al. 2000; Kask et al. 2000).”
BackgroundTarnow, P., Schöneberg, T., Krude, H., Grüters, A., & Biebermann, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309941200 · Cited by 71 · cited 2×
“Since these first descriptions, so far over 150 different mutations in theMC4R gene have been identified (summarized in (Tao 2010a)) with only rare cases in which homozygous or compound heterozygous mutations were identified (Farooqi et al. 2000, 2003; Kobayashi et al. 2002; LubranoBerthelier et al. 2004; Ma et al. 20…”
BackgroundSelf-citationMelanocortin-4 receptors, β-MSH and leptin: Key elements in the satiety pathway
Harrold, J. A., & Williams, G. (2005) · Peptides · doi:10.1016/j.peptides.2005.01.030 · Cited by 71
Mencarelli, M., Dubern, B., Alili, R., Maestrini, S., Benajiba, L., Tagliaferri, M., Galan, P., Rinaldi, M., Simon, C., Tounian, P., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq472 · Cited by 71 · cited 1×
“The physiological effect of mutations in the humanMC3R contributing to obesity is still under strong debate (Calton et al. 2009; Mencarelli et al. 2011).”
BackgroundHeterodimerization of Hypothalamic G-Protein-Coupled Receptors Involved in Weight Regulation
Rediger, A., Tarnow, P., Bickenbach, A., Schaefer, M., Krude, H., Grüters, A., & Biebermann, H. (2009) · Obesity Facts · doi:10.1159/000209862 · Cited by 70 · cited 1×
“Additionally, heterodimerization of MC4R and MC3R with other GPCRs that are involved in weight regulation was demonstrated (Rediger et al. 2009).”
BackgroundSelf-citationSporadic mutations in melanocortin receptor 3 in morbid obese individuals
Mencarelli, M., Walker, G. E., Maestrini, S., Alberti, L., Verti, B., Brunani, A., Petroni, M. L., Tagliaferri, M., Liuzzi, A., & Blasio, A. M. D. (2008) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5202005 · Cited by 70 · cited 2×
“These mutations display either wild-type-like receptor signaling functions (Ala293Thr, Val177Ile, X361Ser, Ala70Thr, Met134Ile) (Lee et al. 2007; Mencarelli et al. 2008; Rached et al. 2004) or reduced signaling properties (Ser17Thr, Thr280Ser, and Ile335Ser, c.”
BackgroundMelanocortin-3-receptor gene variants in morbid obesity
Schalin‐Jäntti, C., Valli‐Jaakola, K., Oksanen, L., Martelin, E., Laitinen, K., Krusius, T., Mustajoki, P., Heikinheimo, M., & KONTULA, K. K. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802184 · Cited by 68 · cited 1×
“In the past decade, numerous studies investigated association of two frequent MC3R variants with obesity or diabetes in various collectives (Feng et al. 2005; Hani et al. 2001; Li et al. 2000; Schalin-Jantti et al. 2003; Wong et al. 2002).”
BackgroundAgRP in energy balance: Will the real AgRP please stand up?
Flier, J. S. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.003 · Cited by 68
Millington, G. W. M., Tung, Y. C. L., Hewson, A. K., O’Rahilly, S., & Dickson, S. L. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00428-6 · Cited by 66
C Garza, J., Kim, C. S., Liu, J., Zhang, W., & Lu, X.-Y. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0009 · Cited by 65
Tao, Y. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.09.002 · Cited by 64 · cited 1×
“2a) (Lee et al. 2002; Mencarelli et al. 2011, 2008; Rached et al. 2004; Tao 2007; Zegers et al. 2011).”
Gantz, I., Tashiro, T., Barcroft, C. L., Konda, Y., Shimoto, Y., Miwa, H., Glover, T. W., Munzert, G. M., & Yamada, T. (1993) · Genomics · doi:10.1006/geno.1993.1448 · Cited by 59
Hani, E. H., Dupont, S., Durand, E., Dina, C., Gallina, S., Gantz, I., & Froguel, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7589 · Cited by 59 · cited 1×
“In the past decade, numerous studies investigated association of two frequent MC3R variants with obesity or diabetes in various collectives (Feng et al. 2005; Hani et al. 2001; Li et al. 2000; Schalin-Jantti et al. 2003; Wong et al. 2002).”
BackgroundIrani, B. G., Xiang, Z., Moore, M. C., Mandel, R. J., & Haskell‐Luevano, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.084 · Cited by 58 · cited 1×
“Voluntary exercise by offering running wheels to MC4R knockout mice impedes the course of obesity (Irani et al. 2005) and implies that even a severe monogenetic defect can be influenced by changing lifestyle habits, at least in rodents.”
BackgroundMelanocortin 4 Receptor Gene Variation Is Associated With Severe Obesity in Pima Indians
Ma, L., Tataranni, P. A., Bogardus, C., & Baier, L. J. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2696 · Cited by 57 · cited 1×
“Since these first descriptions, so far over 150 different mutations in theMC4R gene have been identified (summarized in (Tao 2010a)) with only rare cases in which homozygous or compound heterozygous mutations were identified (Farooqi et al. 2000, 2003; Kobayashi et al. 2002; LubranoBerthelier et al. 2004; Ma et al. 20…”
BackgroundMutations in the melanocortin-3 receptor (MC3R) gene: Impact on human obesity or adiposity.
Tao, Y. (2010) · PubMed · Cited by 54
Deletions of the N‐terminal regions of the human melanocortin receptors
Schiöth, H. B., Petersson, S., Muceniece, R., Szardenings, M., & Wikberg, J. E. S. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00593-0 · Cited by 53
Wang, C., Godar, R. J., Billington, C. J., & Kotz, C. M. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00844.2009 · Cited by 50 · cited 1×
“Injection of BDNF in the PVN reduces food intake and stimulates energy expenditure (Wang et al. 2010).”
BackgroundRached, M., Buronfosse, A., Bégeot, M., & Penhoat, A. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.03.009 · Cited by 50 · cited 5×
“Functional characterization confirmed a complete loss of function despite nearly normal cell surface expression and ligand binding indicating that the mutation constrained the receptor in the inactive state (Rached et al. 2004).”
BackgroundInfluentialChen, M., Cai, M., Aprahamian, C. J., Georgeson, K. E., Hruby, V., Harmon, C. M., & Yang, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702285200 · Cited by 45
Grieco, P., Cai, M., Han, G., Trivedi, D. B., Campiglia, P., Novellino, E., & Hruby, V. J. (2007) · Peptides · doi:10.1016/j.peptides.2007.02.012 · Cited by 44
Characterization of a novel binding partner of the melanocortin-4 receptor: attractin-like protein
HAQQ, A. M., RENÉ, P., KISHI, T., KHONG, K., LEE, C. E., LIU, H., FRIEDMAN, J. M., ELMQUIST, J. K., & CONE, R. D. (2003) · Biochemical Journal · doi:10.1042/bj20031241 · Cited by 42 · cited 1×
“Another protein, the attractrin-like protein (Haqq et al. 2003), interacts with the MC4R and was identified by a yeast two-hybrid approach.”
BackgroundDimerization of the melanocortin 4 receptor: A study using bioluminescence resonance energy transfer
Nickolls, S. A., & Maki, R. A. (2006) · Peptides · doi:10.1016/j.peptides.2004.12.037 · Cited by 42 · cited 1×
“For melanocortin receptors, it was shown that MC3R and MC4R are able to form homodimers (Biebermann et al. 2003; Elsner et al. 2006; Mandrika et al. 2005; Nickolls and Maki 2006).”
BackgroundWong, J., Love, D. R., Kyle, C., Daniels, A., White, M., Stewart, A. W., Schnell, A. H., Elston, R. C., Holdaway, I. M., & Mountjoy, K. G. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00126-2 · Cited by 41 · cited 1×
“In the past decade, numerous studies investigated association of two frequent MC3R variants with obesity or diabetes in various collectives (Feng et al. 2005; Hani et al. 2001; Li et al. 2000; Schalin-Jantti et al. 2003; Wong et al. 2002).”
BackgroundMolecular Characterization of Human Melanocortin-3 Receptor Ligand−Receptor Interaction
Chen, M., Aprahamian, C. J., Çelik, A., Georgeson, K. E., Garvey, W. T., Harmon, C. M., & Yang, Y. (2006) · Biochemistry · doi:10.1021/bi0521792 · Cited by 41
Identification of Three Novel Genetic Variants in the Melanocortin‐3 Receptor of Obese Children
Zegers, D., Beckers, S., de Freitas, F., Peeters, A. V., Mertens, I. L., Verhulst, S. L., Rooman, R., Timmermans, J., Desager, K., Massa, G., et al. (2011) · Obesity · doi:10.1038/oby.2010.127 · Cited by 40 · cited 1×
“2a) (Lee et al. 2002; Mencarelli et al. 2011, 2008; Rached et al. 2004; Tao 2007; Zegers et al. 2011).”
Roubert, P., Dubern, B., Plas, P., Lubrano-Berthelier, C., Alihi, R., Auger, F., Deoliveira, D. B., Dong, J. Z., Basdevant, A., Thurieau, C., et al. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0336 · Cited by 40 · cited 1×
“are able to efficiently activate loss-of-function MC4Rmutations (Roubert et al. 2010).”
BackgroundOosterom, J., Garner, K. M., den Dekker, W. K., Nijenhuis, W. A. J., Gispen, W. H., Burbach, J. P. H., Barsh, G. S., & Adan, R. A. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007261200 · Cited by 40
MC4R oligomerizes independently of extracellular cysteine residues
Elsner, A., Tarnow, P., Schaefer, M., Ambrugger, P., Krude, H., Grüters, A., & Biebermann, H. (2005) · Peptides · doi:10.1016/j.peptides.2005.02.027 · Cited by 36
Self-citationMolecular Pharmacology of Agouti Protein in Vitro and in Vivo
Barsh, G. S., Ollmann, M. M., Wilson, B. D., Miller, K. A., & Gunn, T. M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08671.x · Cited by 36
Increased constraints on MC4R during primate and human evolution
Hughes, D. A., Hinney, A., Brumm, H., Wermter, A., Biebermann, H., Hebebrand, J., & Stoneking, M. (2008) · Human Genetics · doi:10.1007/s00439-008-0591-8 · Cited by 36 · cited 1×
“purification selection with codon usage bias resulting in an intriguingly low level of silent polymorphisms in humans (Hughes et al. 2009).”
BackgroundSelf-citationInsights from the Genetics of Severe Childhood Obesity
Farooqi, S. (2007) · Hormone Research in Paediatrics · doi:10.1159/000110462 · Cited by 36 · cited 1×
“This is combined with ACTH deficiency, pale skin, and red hair in the Caucasian population (Farooqi 2007).”
BackgroundFrom Agouti to Pomc—100 years of fat blonde mice
Barsh, G. S. (1999) · Nature Medicine · doi:10.1038/12415 · Cited by 34
Valli‐Jaakola, K., Palvimo, J. J., Lipsanen‐Nyman, M., Salomaa, V. V., Peltonen, L., KONTULA, K. K., & Schalin‐Jäntti, C. (2006) · Hormone Research in Paediatrics · doi:10.1159/000093469 · Cited by 34 · cited 1×
“So far, only one variation in the 50 untranslated region of MC4R was reported (Lubrano-Berthelier et al. 2003; Valli-Jaakola et al. 2006).”
BackgroundTarnow, P., Rediger, A., Brumm, H., Ambrugger, P., Rettenbacher, E., Widhalm, K., Hinney, A., Kleinau, G., Schaefer, M., Hebebrand, J., et al. (2008) · Obesity Facts · doi:10.1159/000138251 · Cited by 34
Self-citationMolecular cloning and pharmacological characterization of porcine melanocortin-3 receptor
Fan, Z., Sartin, J. L., & Tao, Y. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0403 · Cited by 34
Adan, R. A. H. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.02.002 · Cited by 33 · cited 1×
“Recent studies have indicated that AgRP acts as an inverse agonist (depression of ligand-independent signaling activity) on MC4R and MC1R (Adan 2006).”
BackgroundMolecular Determination of Agouti-Related Protein Binding to Human Melanocortin-4 Receptor
Yang, Y., Chen, M., Lai, Y., Gantz, I., Yağmurlu, A., Georgeson, K. E., & Harmon, C. M. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.1.94 · Cited by 32 · cited 1×
“affinity but not for AgRP 110–117; moreover, amino acid side chains in TMHs 3 and 4 are important for binding of both AgRPs (Yang et al. 2003).”
BackgroundBarth, N., Ziegler, A., Himmelmann, G. W., Coners, H., Wabitsch, M., Hennighausen, K., Mayer, H. G., Remschmidt, H., Schäfer, H., & Hebebrand, J. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800376 · Cited by 32
Grieco, P., Balse, P., Han, G. U., Weinberg, D., MacNeil, T., der Ploeg, L. H. T. V., & Hruby, V. J. (2003) · Journal of Peptide Research · doi:10.1034/j.1399-3011.2003.00087.x · Cited by 29
Energy balance pathways converging on the Nhlh2 transcription factor
Dana, L. F. (2007) · Frontiers in bioscience · doi:10.2741/2365 · Cited by 27 · cited 1×
“Nhlh2 is known to regulate the transcription of PC1 and PC2 (Fox et al. 2007), but regulation of MC4R transcription was not proven yet.”
Backgroundα‐MSH and Desacetyl‐α‐MSH Signaling through Melanocortin Receptors
Mountjoy, K. G., Wu, C., Cornish, J., & Callon, K. E. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03162.x · Cited by 27
Miltenberger, R. J., Mynatt, R. L., Bruce, B. D., Wilkison, W. O., Woychik, R. P., & Michaud, E. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8579 · Cited by 21 · cited 1×
“Heterozygous A animals are viable, but in the mutated allele, the Raly promoter drives ubiquitous expression of agouti resulting in the described phenotype (Miltenberger et al. 1999; Yen et al. 1994).”
BackgroundHe, S., Ye, Z., Dobbelaar, P. H., Sebhat, I. K., Guo, L., Liu, J., Jian, T., Lai, Y., Franklin, C. L., Bakshi, R. K., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.02.058 · Cited by 20
Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesity
He, S., Ye, Z., Dobbelaar, P. H., Sebhat, I. K., Guo, L., Liu, J., Jian, T., Lai, Y., Franklin, C. L., Bakshi, R. K., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.062 · Cited by 19
Guo, L., Ye, Z., Liu, J., He, S., Bakshi, R. K., Sebhat, I. K., Dobbelaar, P. H., Hong, Q., Jian, T., Dellureficio, J., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.068 · Cited by 14
Editorial: The Ups and Downs of Leptin Action
Cone, R. D. (1999) · Endocrinology · doi:10.1210/endo.140.11.7202 · Cited by 7
Melanocortin-4 Receptor as a New Target for Drug Development
Fong, T. M., & Strack, A. M. (2008) · CRC Press eBooks · doi:10.3109/9781420051452-25 · Cited by 5
Cited by
Estrogen deficiency and the origin of obesity during menopause
Lizcano, F., & Guzmán, G. (2014) · BioMed Research International · doi:10.1155/2014/757461 · Cited by 586
“Thepotential therapeutic relevance of estrogen physiology, estrogen receptors, and the estrogen pathway will be discussed in this manuscript.”
BackgroundLeeners, B., Geary, N., Tobler, P. N., & Asarian, L. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmw045 · Cited by 407
“Brain α-MSH neurons signal mainly via MC3R in the ARC and via MC4R in the paraventricular nucleus of the hypothalamus (Biebermann et al., 2012), and loss-of-function polymorphisms of human MC4R lead to voracious appetite and obesity (Dempfle et al., 2004; Stutzmann et al., 2008; Valette et al.,…”
BackgroundAgRP/NPY and POMC neurons in the arcuate nucleus and their potential role in treatment of obesity
Vohra, M. S., Benchoula, K., Serpell, C. J., & Hwa, W. E. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174611 · Cited by 181
Melanocortin-4 Receptor in Energy Homeostasis and Obesity Pathogenesis
(2013) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-386933-3.00005-4 · Cited by 160
Structures of active melanocortin-4 receptor–Gs-protein complexes with NDP-α-MSH and setmelanotide
Heyder, N. A., Kleinau, G., Speck, D., Schmidt, A., Paisdzior, S., Szczepek, M., Bauer, B., Koch, A., Gallandi, M., Kwiatkowski, D., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00569-8 · Cited by 102
Self-citation
Metadata
- Authors
- Biebermann, H., Kühnen, P., Kleinau, G., & Krude, H.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Biebermann, Heike
- Venue
- Handbook of Experimental Pharmacology
- Publisher
- Springer Berlin Heidelberg
- Published
- 2011-12-10
- Issue
- 209
- Pages
- 47-75
- ISSN
- 0171-2004 (ISSN-L)
- 1865-0325
- OpenAlex
- W2136943612
- Cited by
- 70
- References
- 148
- Citations by year
- 2025: 5 · 2024: 3 · 2023: 7 · 2022: 3 · 2021: 6 · 2020: 4 · 2019: 4 · 2018: 2 · 2017: 4 · 2016: 7 · 2015: 3 · 2014: 12 · 2013: 8 · 2012: 2
- FWCI
- 8.73
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Handbook of experimental pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- obesity, leptin-melanocortin pathway, proopiomelanocortin, melanocortin peptides, agouti-related protein, melanocortin-4 receptor, melanocortin 3 receptor, hypothalamus, energy homeostasis, body weight regulation, G protein-coupled receptors, arcuate nucleus, paraventricular nucleus
- MeSH terms
- Animals, Body Weight, Eating, Energy Metabolism, Humans, Hypothalamo-Hypophyseal System, Hypothalamus, Melanocyte-Stimulating Hormones, Mutation, Obesity, Pro-Opiomelanocortin, Signal Transduction, Receptor, Melanocortin, Type 3, Receptor, Melanocortin, Type 4, Agouti-Related Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.